Savella - Milnacipran HCl - Dosage - Side Effects - Drug Interactions
Savella (milnacipran HCl) drug information, dosage, side effects, drug interactions, and warnings. Savella, generic drug name milnacipran HCl, is in the class of antidepressants known as selective serotonin and norepinephrine dual reuptake inhibitors. Savella is the third medication FDA-approved for the treatment of fibromyalgia.
Savella - What You Need to Know
Savella, generic name milnacipran HCl, has been approved by the FDA for the management of fibromyalgia. Savella is a selective serotonin and norepinephrine dual reuptake inhibitor.
Savella, generic name milnacipran HCl, has been approved by the FDA for the management of fibromyalgia. Savella is a selective serotonin and norepinephrine dual reuptake inhibitor.
FDA Defers Action on the New Drug Application for Milnacipran
October 18, 2008, The FDA wasn't able to take final action on the New Drug Application (NDA) for milnacipran, a selective serotonin and norepinephrine reuptake inhibitor for fibromyalgia management. The FDA couldn't provide the reason for the delay, but indicated that their assessment could be completed in a matter of weeks, but couldn't confirm specific timing, from Cypress Bioscience.
October 18, 2008, The FDA wasn't able to take final action on the New Drug Application (NDA) for milnacipran, a selective serotonin and norepinephrine reuptake inhibitor for fibromyalgia management. The FDA couldn't provide the reason for the delay, but indicated that their assessment could be completed in a matter of weeks, but couldn't confirm specific timing, from Cypress Bioscience.
Development Status: Milnacipran
Cypress is developing milnacipran for the treatment of fibromyalgia syndrome (FMS). Milnacipran is the first of a new class of agents known as norepinephrine serotonin reuptake inhibitors, or NSRIs, which increase the level of norepinephrine more than they do serotonin, from Cypress BioScience.
Cypress is developing milnacipran for the treatment of fibromyalgia syndrome (FMS). Milnacipran is the first of a new class of agents known as norepinephrine serotonin reuptake inhibitors, or NSRIs, which increase the level of norepinephrine more than they do serotonin, from Cypress BioScience.
Milnacipran: Results of First Phase III Trial
While the results in our first Phase III trial did not achieve a p-value of less than or equal to 0.05, we believe the results support continued development of milnacipran as a treatment for FMS. The ongoing development program for milnacipran includes an ongoing second Phase III study and an additional third Phase III study, from Cypress Bioscience.
While the results in our first Phase III trial did not achieve a p-value of less than or equal to 0.05, we believe the results support continued development of milnacipran as a treatment for FMS. The ongoing development program for milnacipran includes an ongoing second Phase III study and an additional third Phase III study, from Cypress Bioscience.
Milnacipran From Wikipedia
In experimental studies Milnacipran showed useful activity as adjunct in the therapy of Fibromyalgia and Lupus, both conditions with potentially devastating effects. In January 2006, Forest Pharmaceuticals and Cypress Bioscience agreed to commence a phase III multicenter study encompassing 1,200 patients with Fibromyalgia. Early results will be available by mid 2007, from Wikipedia.
In experimental studies Milnacipran showed useful activity as adjunct in the therapy of Fibromyalgia and Lupus, both conditions with potentially devastating effects. In January 2006, Forest Pharmaceuticals and Cypress Bioscience agreed to commence a phase III multicenter study encompassing 1,200 patients with Fibromyalgia. Early results will be available by mid 2007, from Wikipedia.
Fibromyalgia Medication Options - How Is Fibromyalgia Treated?
There are no medications approved by the FDA for treating fibromyalgia, although a few such drugs are in development. Doctors treat fibromyalgia with a variety of medications developed and approved for other purposes.
There are no medications approved by the FDA for treating fibromyalgia, although a few such drugs are in development. Doctors treat fibromyalgia with a variety of medications developed and approved for other purposes.
Fibromyalgia Screening Quiz
Fibromyalgia is difficult to diagnose. Combinations of symptoms can occur which overlap with other autoimmune diseases. There are symptoms which are considered "defining" of fibromyalgia. There are also symptoms considered "non-defining" but they often occur as part of fibromyalgia syndrome.
Fibromyalgia is difficult to diagnose. Combinations of symptoms can occur which overlap with other autoimmune diseases. There are symptoms which are considered "defining" of fibromyalgia. There are also symptoms considered "non-defining" but they often occur as part of fibromyalgia syndrome.
Fibromyalgia - Test Your Knowledge
Fibromyalgia is often regarded as a medical enigma. Symptoms of fibromyalgia syndrome can overlap with other conditions making it difficult to diagnose. How much do you know about fibromyalgia?
Fibromyalgia is often regarded as a medical enigma. Symptoms of fibromyalgia syndrome can overlap with other conditions making it difficult to diagnose. How much do you know about fibromyalgia?
The Fibromyalgia Guide - Free Newsletter E-Course
Fibromyalgia is a condition characterized by body aches, pain, sleep problems, extreme fatigue, depression and anxiety, in combination with tenderness of specific areas (muscles and tender points) on the body. Learn more about fibromyalgia by signing up for our free newsletter e-course.
Fibromyalgia is a condition characterized by body aches, pain, sleep problems, extreme fatigue, depression and anxiety, in combination with tenderness of specific areas (muscles and tender points) on the body. Learn more about fibromyalgia by signing up for our free newsletter e-course.